A citation-based method for searching scientific literature


List of co-cited articles
164 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Combined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults.
E Rapti, S Karras, M Grammatiki, A Mousiolis, X Tsekmekidou, E Potolidis, P Zebekakis, M Daniilidis, K Kotsa. Endocrinol Diabetes Metab Case Rep 2016
21
63

C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.
Odd Erik Johansen, Bernhard O Boehm, Valdemar Grill, Peter A Torjesen, Sudipta Bhattacharya, Sanjay Patel, Kristiane Wetzel, Hans-Juergen Woerle. Diabetes Care 2014
42
63

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
73
54

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Margareth Afonso Torres. Endocrinol Diabetes Metab Case Rep 2016
14
54

Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).
R Buzzetti, P Pozzilli, R Frederich, N Iqbal, B Hirshberg. Diabetes Metab Res Rev 2016
32
54

Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Marcelo Maia Pinheiro, Caroline Lais Stoppa, Claudete Justina Valduga, Cristina Eunice Okuyama, Renata Gorjão, Regina Mara Silva Pereira, Susana Nogueira Diniz. Eur J Pharm Sci 2017
39
45

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).
Takuya Awata, Akira Shimada, Taro Maruyama, Yoichi Oikawa, Nobuyuki Yasukawa, Susumu Kurihara, Yumi Miyashita, Masako Hatano, Yuichi Ikegami, Masafumi Matsuda,[...]. Diabetes Ther 2017
24
45


Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhiguang Zhou, Yufei Xiang, Linong Ji, Weiping Jia, Guang Ning, Gan Huang, Lin Yang, Jian Lin, Zhenqi Liu, William A Hagopian,[...]. Diabetes 2013
136
36


Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
84
36


Adult-onset autoimmune diabetes: current knowledge and implications for management.
Raffaella Buzzetti, Simona Zampetti, Ernesto Maddaloni. Nat Rev Endocrinol 2017
80
36

Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
Xia Li, Lan Liao, Xiang Yan, Gan Huang, Jian Lin, Minxiang Lei, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2009
70
36

Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).
Bertram Bengsch, Bianca Seigel, Tobias Flecken, Julia Wolanski, Hubert E Blum, Robert Thimme. J Immunol 2012
101
27

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
36
27

The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization.
Payal Shah, Amin Ardestani, Gitanjali Dharmadhikari, Svenja Laue, Desiree M Schumann, Julie Kerr-Conte, Francois Pattou, Thomas Klein, Kathrin Maedler. J Clin Endocrinol Metab 2013
64
27

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
Shelley Lindley, Colin M Dayan, Amanda Bishop, Bart O Roep, Mark Peakman, Timothy I M Tree. Diabetes 2005
589
27

IL-17 immunity in human type 1 diabetes.
Jarno Honkanen, Janne K Nieminen, Ru Gao, Kristiina Luopajarvi, Harri M Salo, Jorma Ilonen, Mikael Knip, Timo Otonkoski, Outi Vaarala. J Immunol 2010
181
27

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
S L Ellis, E G Moser, J K Snell-Bergeon, A S Rodionova, R M Hazenfield, S K Garg. Diabet Med 2011
89
27

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
66
27

Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials.
Paolo Pozzilli, Richard D Leslie, Anne L Peters, Raffaella Buzzetti, Sudha S Shankar, Zvonko Milicevic, Imre Pavo, Jeremie Lebrec, Sherry Martin, Nanette C Schloot. Diabetes Obes Metab 2018
19
27

First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes.
Diana L Cousminer, Emma Ahlqvist, Rajashree Mishra, Mette K Andersen, Alessandra Chesi, Mohammad I Hawa, Asa Davis, Kenyaita M Hodge, Jonathan P Bradfield, Kaixin Zhou,[...]. Diabetes Care 2018
52
27


Latent autoimmune diabetes in adults (LADA) should be less latent.
S Fourlanos, F Dotta, C J Greenbaum, J P Palmer, O Rolandsson, P G Colman, L C Harrison. Diabetologia 2005
197
27

Beta-cell protection and therapy for latent autoimmune diabetes in adults.
Simona Cernea, Raffaella Buzzetti, Paolo Pozzilli. Diabetes Care 2009
30
27


Latent autoimmune diabetes in adults.
Ramachandra G Naik, Barbara M Brooks-Worrell, Jerry P Palmer. J Clin Endocrinol Metab 2009
117
27

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Raffaella Buzzetti, Sergio Di Pietro, Andrea Giaccari, Antonio Petrone, Mattia Locatelli, Concetta Suraci, Marco Capizzi, Maria Luisa Arpi, Elena Bazzigaluppi, Francesco Dotta,[...]. Diabetes Care 2007
138
27

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study.
E Hyppönen, E Läärä, A Reunanen, M R Järvelin, S M Virtanen. Lancet 2001
27

Administering 25-hydroxyvitamin D3 in vitamin D-deficient young type 1A diabetic patients reduces reactivity against islet autoantigens.
G Federico, D Focosi, B Marchi, E Randazzo, M De Donno, F Vierucci, M Bugliani, F Campi, F Scatena, G Saggese,[...]. Clin Nutr 2014
12
27

Vitamin D: a novel player in endothelial function and dysfunction.
Massimiliano Caprio, Caterina Mammi, Giuseppe M C Rosano. Arch Med Sci 2012
32
27

Vitamin D Switches BAF Complexes to Protect β Cells.
Zong Wei, Eiji Yoshihara, Nanhai He, Nasun Hah, Weiwei Fan, Antonio F M Pinto, Timothy Huddy, Yuhao Wang, Brittany Ross, Gabriela Estepa,[...]. Cell 2018
71
27

Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.
Massimiliano Caprio, Marco Infante, Matilde Calanchini, Caterina Mammi, Andrea Fabbri. Eat Weight Disord 2017
61
27

Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
Lingjiao Liu, Xia Li, Yufei Xiang, Gan Huang, Jian Lin, Lin Yang, Yunjuan Zhao, Zhifang Yang, Can Hou, Yijun Li,[...]. Diabetes Care 2015
51
27


A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
Noriko Satoh-Asahara, Yousuke Sasaki, Hiromichi Wada, Mayu Tochiya, Azusa Iguchi, Reiko Nakagawachi, Shinji Odori, Shigeo Kono, Koji Hasegawa, Akira Shimatsu. Metabolism 2013
124
27

Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
171
27

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
Raffaella Buzzetti, Tiinamaija Tuomi, Didac Mauricio, Massimo Pietropaolo, Zhiguang Zhou, Paolo Pozzilli, Richard David Leslie. Diabetes 2020
14
27

Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes.
André J Tremblay, Benoît Lamarche, Carolyn F Deacon, S John Weisnagel, Patrick Couture. Metabolism 2014
82
27

Adding vitamin D3 to the dipeptidyl peptidase-4 inhibitor saxagliptin has the potential to protect β-cell function in LADA patients: A 1-year pilot study.
Ziwei Zhang, Xiang Yan, Chao Wu, Xieyi Pei, Xia Li, Xiangbing Wang, Xiaohong Niu, Hongwei Jiang, Xiaomin Zeng, Zhiguang Zhou. Diabetes Metab Res Rev 2020
9
33

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
G F Bottazzo, E Bosi, C A Cull, E Bonifacio, M Locatelli, P Zimmet, I R Mackay, R R Holman. Diabetologia 2005
63
18

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.
Juliet A Emamaullee, Joy Davis, Shaheed Merani, Christian Toso, John F Elliott, Aducio Thiesen, A M James Shapiro. Diabetes 2009
257
18

Sitagliptin in glutamic acid decarboxylase antibody-positive diabetes mellitus.
Narayanan Kandasamy, Graham Lennox, Anand K Annamalai, Gerald Maguire, Amanda I Adler. Endocr Pract 2012
9
22

Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.
Chao Deng, Yufei Xiang, Tingting Tan, Zhihui Ren, Chuqing Cao, Gan Huang, Li Wen, Zhiguang Zhou. Diabetes Care 2016
53
18

Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study.
Zhifang Yang, Zhiguang Zhou, Xia Li, Gan Huang, Jian Lin. Diabetes Res Clin Pract 2009
38
18

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
James Mu, John Woods, Yun-Ping Zhou, Ranabir Sinha Roy, Zhihua Li, Emanuel Zycband, Yue Feng, Lan Zhu, Cai Li, Andrew D Howard,[...]. Diabetes 2006
351
18

Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency.
C Akesson, K Uvebrant, C Oderup, K Lynch, R A Harris, A Lernmark, C-D Agardh, C M Cilio. Clin Exp Immunol 2010
26
18

The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
Yunjuan Zhao, Lin Yang, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2014
39
18

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
Núria Alonso, María Teresa Julián, Jorge Carrascal, Roger Colobran, Irma Pujol-Autonell, Silvia Rodriguez-Fernández, Aina Teniente, Marco Antonio Fernández, Antoni Miñarro, María Carmen Ruiz de Villa,[...]. PLoS One 2015
7
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.